HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Steven A Rosenberg Selected Research

Protein Subunit Vaccines

6/2011gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.
7/2010Different adjuvanticity of incomplete freund's adjuvant derived from beef or vegetable components in melanoma patients immunized with a peptide vaccine.
1/2004Phenotypic and functional maturation of tumor antigen-reactive CD8+ T lymphocytes in patients undergoing multiple course peptide vaccination.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Steven A Rosenberg Research Topics

Disease

279Neoplasms (Cancer)
01/2022 - 01/2002
180Melanoma (Melanoma, Malignant)
01/2022 - 01/2002
22Neoplasm Metastasis (Metastasis)
10/2019 - 05/2002
14Renal Cell Carcinoma (Grawitz Tumor)
01/2015 - 01/2002
12Testicular Neoplasms (Testicular Cancer)
11/2020 - 04/2005
10Kidney Neoplasms (Kidney Cancer)
06/2014 - 05/2002
7Experimental Melanoma
06/2013 - 08/2004
6Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 10/2010
6Brain Neoplasms (Brain Tumor)
06/2018 - 01/2002
5Glioblastoma (Glioblastoma Multiforme)
01/2021 - 12/2008
5Lymphoma (Lymphomas)
01/2020 - 11/2010
5Ovarian Neoplasms (Ovarian Cancer)
11/2019 - 05/2003
5Adenocarcinoma
01/2019 - 01/2009
5Leukemia
01/2019 - 09/2009
5Sarcoma (Soft Tissue Sarcoma)
03/2015 - 03/2011
4Breast Neoplasms (Breast Cancer)
01/2022 - 01/2014
4Gastrointestinal Neoplasms (Gastrointestinal Cancer)
11/2020 - 09/2013
4Colonic Neoplasms (Colon Cancer)
01/2019 - 10/2003
4Lymphopenia (Lymphocytopenia)
01/2017 - 05/2002
4Thrombocytopenia (Thrombopenia)
01/2017 - 01/2002
4Synovial Sarcoma (Synovioma)
01/2016 - 08/2011
3Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2019 - 05/2015
3Carcinoma (Carcinomatosis)
01/2019 - 02/2003
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2017 - 05/2003
3Graft vs Host Disease (Graft-Versus-Host Disease)
04/2016 - 12/2008
3Colorectal Neoplasms (Colorectal Cancer)
03/2011 - 10/2003
3Fowlpox
10/2009 - 08/2003
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2020 - 02/2015
2Hematologic Neoplasms (Hematological Malignancy)
01/2019 - 04/2016
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2019 - 01/2018
2Disease Progression
01/2017 - 12/2010

Drug/Important Bio-Agent (IBA)

102AntigensIBA
01/2022 - 01/2002
58T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2022 - 02/2004
58Interleukin-2 (IL2)IBA
10/2021 - 01/2002
42Neoplasm Antigens (Tumor Antigens)IBA
01/2022 - 05/2002
39Peptides (Polypeptides)IBA
01/2021 - 01/2002
32Chimeric Antigen ReceptorsIBA
01/2020 - 09/2009
30CytokinesIBA
01/2020 - 05/2002
27EpitopesIBA
01/2022 - 05/2002
27Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2002
17HLA-A*02:01 antigenIBA
01/2019 - 05/2002
16VaccinesIBA
11/2020 - 06/2002
12Differentiation AntigensIBA
11/2020 - 05/2002
10InterleukinsIBA
01/2018 - 08/2003
9Biomarkers (Surrogate Marker)IBA
11/2020 - 05/2003
9Interleukin-15 (Interleukin 15)IBA
01/2018 - 02/2004
9AutoantigensIBA
05/2017 - 09/2002
8Interleukin-12 (IL 12)IBA
01/2020 - 09/2010
8Monophenol Monooxygenase (Tyrosinase)IBA
05/2014 - 01/2002
7HLA Antigens (Human Leukocyte Antigens)IBA
11/2018 - 05/2003
7IpilimumabIBA
10/2013 - 05/2006
7Melanoma-Specific AntigensIBA
10/2010 - 01/2002
7CTLA-4 AntigenIBA
07/2008 - 07/2003
6HLA-A Antigens (HLA-A)IBA
01/2022 - 05/2008
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2013 - 07/2003
6fludarabineIBA
05/2011 - 05/2002
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2011 - 05/2002
5Interferon-gamma (Interferon, gamma)IBA
01/2020 - 03/2009
5LigandsIBA
01/2019 - 08/2003
5gp100 Melanoma AntigenIBA
10/2009 - 08/2003
4HLA-C Antigens (HLA-C)IBA
01/2022 - 11/2012
4InterferonsIBA
01/2021 - 11/2010
4RNA (Ribonucleic Acid)IBA
05/2017 - 04/2005
4Complementary DNA (cDNA)IBA
04/2016 - 07/2002
4DNA (Deoxyribonucleic Acid)IBA
01/2016 - 05/2003
4Glycoproteins (Glycoprotein)IBA
12/2014 - 09/2003
4SteroidsIBA
10/2012 - 05/2006
4incomplete Freund's adjuvantIBA
06/2011 - 05/2004
4Monoclonal AntibodiesIBA
04/2010 - 11/2004
4Cancer VaccinesIBA
11/2006 - 05/2003
3Immune Checkpoint InhibitorsIBA
01/2022 - 01/2019
3Messenger RNA (mRNA)IBA
01/2022 - 01/2006
3epidermal growth factor receptor VIIIIBA
01/2019 - 10/2012
3ErbB Receptors (EGF Receptor)IBA
01/2019 - 10/2012
3Immunodominant EpitopesIBA
06/2013 - 05/2003
3interferon tauIBA
06/2013 - 12/2008
3SuspensionsIBA
10/2012 - 12/2008
3T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
07/2012 - 07/2002
3Small Interfering RNA (siRNA)IBA
09/2011 - 10/2009
3Interleukin-7 (Interleukin 7)IBA
08/2011 - 01/2005
3Protein Subunit VaccinesIBA
06/2011 - 01/2004
3Therapeutic UsesIBA
09/2010 - 05/2003
3Angiogenesis InhibitorsIBA
08/2010 - 05/2003
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2010 - 05/2002
2Cysteine (L-Cysteine)FDA Link
01/2020 - 12/2018
2PlatinumIBA
10/2019 - 05/2015
2Mutant Proteins (Protein, Mutant)IBA
01/2019 - 01/2018
2DisulfidesIBA
12/2018 - 06/2010
2ElementsIBA
11/2018 - 03/2009
2HLA-DPB1 antigen (HLA DPB1)IBA
10/2017 - 01/2016
2Immunoglobulins (Immunoglobulin)IBA
08/2017 - 05/2014
2Carrier Proteins (Binding Protein)IBA
08/2017 - 07/2010
2VemurafenibIBA
01/2017 - 10/2013

Therapy/Procedure

124Therapeutics
01/2022 - 01/2002
124Immunotherapy
01/2022 - 01/2002
30Cell- and Tissue-Based Therapy (Cell Therapy)
11/2019 - 04/2008
26Drug Therapy (Chemotherapy)
06/2017 - 01/2002
7Aftercare (After-Treatment)
10/2019 - 05/2009
3Metastasectomy
01/2017 - 08/2004
3Intravenous Administration
09/2003 - 01/2002